Cabergoline (Par Pharmaceutical, Inc.)


Welcome to the PulseAid listing for the Cabergoline drug offered from Par Pharmaceutical, Inc.. This Ergolines [Chemical/Ingredient],Ergot Derivative [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Par Pharmaceutical, Inc.
NON-PROPRIETARY NAME: Cabergoline
SUBSTANCE NAME: CABERGOLINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Ergolines [Chemical/Ingredient],Ergot Derivative [EPC]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2005-12-29
END MARKETING DATE: 0000-00-00


Cabergoline HUMAN PRESCRIPTION DRUG Details:

Item DescriptionCabergoline from Par Pharmaceutical, Inc.
LABELER NAME: Par Pharmaceutical, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 0.5(mg/1)
START MARKETING DATE: 2005-12-29
END MARKETING DATE: 0000-00-00
PRODUCT ID: 49884-673_1bef161f-47c6-445e-8006-dec4a68f5ed6
PRODUCT NDC: 49884-673
APPLICATION NUMBER: ANDA076310

Other CABERGOLINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Apotex Corp.CABERGOLINE
Avera McKennan HospitalCabergoline
Greenstone LLCCabergoline
Mylan Pharmaceuticals Inc.Cabergoline
Par Pharmaceutical, Inc.Cabergoline
Teva Pharmaceuticals USA IncCabergoline